Floatz logo

Therapeutic Asset Ratings

164 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Jnj-95298177
Prostate Neoplasm
Janssen Research & Development, LLCP1C (39)
Jnj-95437446
Colorectal Neoplasm
Janssen Research & Development, LLCP1C (39)
Jnj-95566692
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1C (39)
Ami-Hc
Neoplasm
Janssen Research & Development, LLCP1C (37)
Ami-Hc-Cf
Neoplasm
Janssen Research & Development, LLCP1C (37)
Ami-Lc
Neoplasm
Janssen Research & Development, LLCP1C (37)
Ami-Lc-Md
Neoplasm
Janssen Research & Development, LLCP1C (37)
Bleximenib
Acute Lymphoblastic Leukemia
Janssen Research & Development, LLCP1C (37)
Immunoglobulin G4, anti-(human CD3 antigen) (recombinant human monoclonal JNJ-75348780 ?4-chain), disulfide with recombinant human monoclonal JNJ-75348780 ? chain, (229?126?),(232?129?)-bis(disulfide) with immunoglobulin, anti-(human sialic acid-binding Ig-like lectin 2) (recombinant human single-domain VHH fragment)
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1C (37)
Immunoglobulin G4, anti-(human CD3 antigen) (recombinant human monoclonal JNJ-75348780 ?4-chain), disulfide with recombinant human monoclonal JNJ-75348780 ? chain, (229?126?),(232?129?)-bis(disulfide) with immunoglobulin, anti-(human sialic acid-binding Ig-like lectin 2) (recombinant human single-domain VHH fragment)
Neoplasm
Janssen Research & Development, LLCP1C (37)
Immunoglobulin G4, anti-(human CD3 antigen) (recombinant human monoclonal JNJ-75348780 ?4-chain), disulfide with recombinant human monoclonal JNJ-75348780 ? chain, (229?126?),(232?129?)-bis(disulfide) with immunoglobulin, anti-(human sialic acid-binding Ig-like lectin 2) (recombinant human single-domain VHH fragment)
Solid Tumor, Adult
Janssen Research & Development, LLCP1C (37)
Jnj-54179060
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1C (37)
Jnj-54179060
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-54179060
Solid Tumor, Adult
Janssen Research & Development, LLCP1C (37)
Jnj-64264681
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1C (37)
Jnj-64264681
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-64264681
Solid Tumor, Adult
Janssen Research & Development, LLCP1C (37)
Jnj-70218902
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1C (37)
Jnj-70218902
Solid Tumor, Adult
Janssen Research & Development, LLCP1C (37)
Jnj-74856665
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-74856665
Solid Tumor, Adult
Janssen Research & Development, LLCP1C (37)
Jnj-75276617
Acute Lymphoblastic Leukemia
Janssen Research & Development, LLCP1C (37)
Jnj-80948543
Myelodysplastic Syndrome
Janssen Research & Development, LLCP1C (37)
Jnj-80948543
Neoplasm
Janssen Research & Development, LLCP1C (37)
Jnj-80948543
Solid Tumor, Adult
Janssen Research & Development, LLCP1C (37)
Showing 126 to 150 of 164 assets
PreviousPage 6 of 7Next